[1]
Dr. Thangjam Kalidas Singh et al. 2022. SPECTRUM, RISK FACTORS, AND CLINICAL OUTCOMES OF FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS: A HOSPITAL-BASED STUDY FROM NORTH INDIA. Journal of Population Therapeutics and Clinical Pharmacology. 29, 03 (Sep. 2022), 2378–2384. DOI:https://doi.org/10.69980/4fn22e40.